The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nucleic Acid Amplification Testing-Global Market Insights and Sales Trends 2024
Synopsis
The global Nucleic Acid Amplification Testing market size is expected to reach US$ 184.9 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Nucleic Acid Amplification Testing in various end use industries. The expanding demands from the Infectious Diseases, Cancer, Personalized Medicine and Genetic and Mitochondrial Disorders, are propelling Nucleic Acid Amplification Testing market. Target Amplification Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Probe Amplification Systems segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Nucleic Acid Amplification Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Nucleic Acid Amplification Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nucleic Acid Amplification Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nucleic Acid Amplification Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nucleic Acid Amplification Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nucleic Acid Amplification Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nucleic Acid Amplification Testing covered in this report include Roche, Becton Dickinson, Beckman Coulter, Abbott, Illumina, Siemens Healthineers, bioMerieux, Novartis and Bio-Rad Laboratories, etc.
The global Nucleic Acid Amplification Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Becton Dickinson
Beckman Coulter
Abbott
Illumina
Siemens Healthineers
bioMerieux
Novartis
Bio-Rad Laboratories
Global Nucleic Acid Amplification Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nucleic Acid Amplification Testing market, Segment by Type:
Target Amplification Systems
Probe Amplification Systems
Signal Amplification
Global Nucleic Acid Amplification Testing market, by Application
Infectious Diseases
Cancer
Personalized Medicine
Genetic and Mitochondrial Disorders
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nucleic Acid Amplification Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Nucleic Acid Amplification Testing market size is expected to reach US$ 184.9 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Nucleic Acid Amplification Testing in various end use industries. The expanding demands from the Infectious Diseases, Cancer, Personalized Medicine and Genetic and Mitochondrial Disorders, are propelling Nucleic Acid Amplification Testing market. Target Amplification Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Probe Amplification Systems segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Nucleic Acid Amplification Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Nucleic Acid Amplification Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nucleic Acid Amplification Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nucleic Acid Amplification Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nucleic Acid Amplification Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nucleic Acid Amplification Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nucleic Acid Amplification Testing covered in this report include Roche, Becton Dickinson, Beckman Coulter, Abbott, Illumina, Siemens Healthineers, bioMerieux, Novartis and Bio-Rad Laboratories, etc.
The global Nucleic Acid Amplification Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Becton Dickinson
Beckman Coulter
Abbott
Illumina
Siemens Healthineers
bioMerieux
Novartis
Bio-Rad Laboratories
Global Nucleic Acid Amplification Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nucleic Acid Amplification Testing market, Segment by Type:
Target Amplification Systems
Probe Amplification Systems
Signal Amplification
Global Nucleic Acid Amplification Testing market, by Application
Infectious Diseases
Cancer
Personalized Medicine
Genetic and Mitochondrial Disorders
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nucleic Acid Amplification Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Nucleic Acid Amplification Testing
1.1 Nucleic Acid Amplification Testing Market Overview
1.1.1 Nucleic Acid Amplification Testing Product Scope
1.1.2 Nucleic Acid Amplification Testing Market Status and Outlook
1.2 Global Nucleic Acid Amplification Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nucleic Acid Amplification Testing Market Size by Region (2018-2029)
1.4 Global Nucleic Acid Amplification Testing Historic Market Size by Region (2018-2023)
1.5 Global Nucleic Acid Amplification Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nucleic Acid Amplification Testing Market Size (2018-2029)
1.6.1 North America Nucleic Acid Amplification Testing Market Size (2018-2029)
1.6.2 Europe Nucleic Acid Amplification Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Nucleic Acid Amplification Testing Market Size (2018-2029)
1.6.4 Latin America Nucleic Acid Amplification Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Nucleic Acid Amplification Testing Market Size (2018-2029)
2 Nucleic Acid Amplification Testing Market by Type
2.1 Introduction
2.1.1 Target Amplification Systems
2.1.2 Probe Amplification Systems
2.1.3 Signal Amplification
2.2 Global Nucleic Acid Amplification Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nucleic Acid Amplification Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Nucleic Acid Amplification Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nucleic Acid Amplification Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nucleic Acid Amplification Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nucleic Acid Amplification Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nucleic Acid Amplification Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nucleic Acid Amplification Testing Revenue Breakdown by Type (2018-2029)
3 Nucleic Acid Amplification Testing Market Overview by Application
3.1 Introduction
3.1.1 Infectious Diseases
3.1.2 Cancer
3.1.3 Personalized Medicine
3.1.4 Genetic and Mitochondrial Disorders
3.2 Global Nucleic Acid Amplification Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nucleic Acid Amplification Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Nucleic Acid Amplification Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nucleic Acid Amplification Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nucleic Acid Amplification Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nucleic Acid Amplification Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nucleic Acid Amplification Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nucleic Acid Amplification Testing Revenue Breakdown by Application (2018-2029)
4 Nucleic Acid Amplification Testing Competition Analysis by Players
4.1 Global Nucleic Acid Amplification Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nucleic Acid Amplification Testing as of 2022)
4.3 Date of Key Players Enter into Nucleic Acid Amplification Testing Market
4.4 Global Top Players Nucleic Acid Amplification Testing Headquarters and Area Served
4.5 Key Players Nucleic Acid Amplification Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Nucleic Acid Amplification Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Nucleic Acid Amplification Testing Products, Services and Solutions
5.1.4 Roche Nucleic Acid Amplification Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Becton Dickinson
5.2.1 Becton Dickinson Profile
5.2.2 Becton Dickinson Main Business
5.2.3 Becton Dickinson Nucleic Acid Amplification Testing Products, Services and Solutions
5.2.4 Becton Dickinson Nucleic Acid Amplification Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Becton Dickinson Recent Developments
5.3 Beckman Coulter
5.3.1 Beckman Coulter Profile
5.3.2 Beckman Coulter Main Business
5.3.3 Beckman Coulter Nucleic Acid Amplification Testing Products, Services and Solutions
5.3.4 Beckman Coulter Nucleic Acid Amplification Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Recent Developments
5.4 Abbott
5.4.1 Abbott Profile
5.4.2 Abbott Main Business
5.4.3 Abbott Nucleic Acid Amplification Testing Products, Services and Solutions
5.4.4 Abbott Nucleic Acid Amplification Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Recent Developments
5.5 Illumina
5.5.1 Illumina Profile
5.5.2 Illumina Main Business
5.5.3 Illumina Nucleic Acid Amplification Testing Products, Services and Solutions
5.5.4 Illumina Nucleic Acid Amplification Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Illumina Recent Developments
5.6 Siemens Healthineers
5.6.1 Siemens Healthineers Profile
5.6.2 Siemens Healthineers Main Business
5.6.3 Siemens Healthineers Nucleic Acid Amplification Testing Products, Services and Solutions
5.6.4 Siemens Healthineers Nucleic Acid Amplification Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Siemens Healthineers Recent Developments
5.7 bioMerieux
5.7.1 bioMerieux Profile
5.7.2 bioMerieux Main Business
5.7.3 bioMerieux Nucleic Acid Amplification Testing Products, Services and Solutions
5.7.4 bioMerieux Nucleic Acid Amplification Testing Revenue (US$ Million) & (2018-2023)
5.7.5 bioMerieux Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Nucleic Acid Amplification Testing Products, Services and Solutions
5.8.4 Novartis Nucleic Acid Amplification Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Novartis Recent Developments
5.9 Bio-Rad Laboratories
5.9.1 Bio-Rad Laboratories Profile
5.9.2 Bio-Rad Laboratories Main Business
5.9.3 Bio-Rad Laboratories Nucleic Acid Amplification Testing Products, Services and Solutions
5.9.4 Bio-Rad Laboratories Nucleic Acid Amplification Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Bio-Rad Laboratories Recent Developments
6 North America
6.1 North America Nucleic Acid Amplification Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nucleic Acid Amplification Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Amplification Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nucleic Acid Amplification Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Amplification Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nucleic Acid Amplification Testing Market Dynamics
11.1 Nucleic Acid Amplification Testing Industry Trends
11.2 Nucleic Acid Amplification Testing Market Drivers
11.3 Nucleic Acid Amplification Testing Market Challenges
11.4 Nucleic Acid Amplification Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
